Open Access745 Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti-TNF Biologic Agents
Author(s) -
Weston Bettner,
Andrew D. Althouse,
Claudia Ramos Rivers,
Marc Schwartz,
Siobhan Proksell,
Elyse Johnston,
Arthur Barrie,
Jana Al Hashash,
Janet Harrison,
Dmitriy Babichenko,
Gong Tang,
Ioannis Ε. Koutroubakis,
David G. Binion
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592516.03670.22
Subject(s) - medicine , ulcerative colitis , inflammatory bowel disease , hazard ratio , prednisone , thiopurine methyltransferase , crohn's disease , biomarker , prospective cohort study , cohort study , proportional hazards model , gastroenterology , cohort , calprotectin , disease , immunology , confidence interval , biochemistry , chemistry